Literature DB >> 22530898

Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives.

Khalid Mohammed Khan1, Momin Khan, Nida Ambreen, Fazal Rahim, Shagufta Naureen, Shahnaz Perveen, M Iqbal Choudhary, Wolfgang Voelter.   

Abstract

Benzimidazole derivatives 1-24 have been synthesized and their in vitro β-glucuronidase inhibitory activitiy was evaluated. Compounds 15 (IC50=6.33+/-0.40 μM), 7 (IC50=22.0+/-0.33 μM), 2 (IC50=23.1+/-1.78 μM), 17 (IC50=23.9+/-1.46 μM), and 3 (IC50=33.8+/-1.61 μM) showed more potent β-glucuronidase inhibitory activity than the standard (D-saccharic acid 1,4 lactone, IC50=48.4+/-1.25 μM). This study has identified a new series of potential β-glucuronidase inhibitors. A structure-activity relationship has also been studied.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22530898     DOI: 10.2174/1573406411208030421

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  4 in total

1.  Evaluation of the thiazole Schiff bases as β-glucuronidase inhibitors and their in silico studies.

Authors:  Khalid Mohammed Khan; Aneela Karim; Sumayya Saied; Nida Ambreen; Xayale Rustamova; Shagufta Naureen; Sajid Mansoor; Muhammad Ali; Shahnaz Perveen; M Iqbal Choudhary; Guillermo Antonio Morales
Journal:  Mol Divers       Date:  2014-02-18       Impact factor: 2.943

Review 2.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Authors:  Paul Awolade; Nosipho Cele; Nagaraju Kerru; Lalitha Gummidi; Ebenezer Oluwakemi; Parvesh Singh
Journal:  Eur J Med Chem       Date:  2019-12-04       Impact factor: 6.514

3.  Benzimidazole, coumrindione and flavone derivatives as alternate UV laser desorption ionization (LDI) matrices for peptides analysis.

Authors:  Syed Ghulam Musharraf; Aisha Bibi; Najia Shahid; Muhammad Najam-Ul-Haq; Nida Ambreen; Momin Khan; Khalid Mohammed Khan; M Iqbal Choudhary; Atta Ur Rahman
Journal:  Chem Cent J       Date:  2013-04-26       Impact factor: 4.215

4.  2-(4-Hy-droxy-phen-yl)-1H-benzimidazol-3-ium chloride monohydrate.

Authors:  Jazmin E González-Padilla; Martha Cecila Rosales-Hernández; Itzia I Padilla-Martínez; Efren V García-Báez; Susana Rojas-Lima
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.